HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TRANSTHERA-B

192.000

+19.30011.18%

Volume:7.86M

Turnover:1.53B

Market Cap:76.22B

PE:-244.66

High:217.000

Open:169.000

Low:168.900

Close:172.700

52wk High:679.500

52wk Low:20.200

Shares:397.00M

HK Float Shares:301.67M

Volume Ratio:1.20

T/O Rate:2.61%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.785

ROE:-39.08%

ROA:-21.10%

PB:120.05

PE(LYR):-244.66

PS:- -

Loading ...

Overview Company News Filings

TransThera Gets US FDA Fast Track Designation for Prostate Cancer Drug; Shares Up 3%

MT Newswires Live

BRIEF-Transthera Sciences (Nanjing) Inc Says Grant Of Tinengotinib (Tt-00420) Fast Track Designation

HK Movers | Biopharmaceutical Company TransThera Soars 80% on Debut

Tiger Newspress

Stock Track | TransThera Sciences Soars 63% on Hong Kong Debut Following Oversubscribed IPO

TransThera Sciences Raises HK$161 Million from IPO Ahead of Hong Kong Trading Debut

MT Newswires Live

TransThera Sciences Launches Up to HK$201 Million IPO in Hong Kong

MT Newswires Live

BRIEF-Transthera Sciences (Nanjing) Says Number Of Offer Shares Under Global Offering 15.3 Million H Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02617/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":192,"timestamp":1761120495743,"preClose":172.7,"halted":0,"volume":7860556,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7847647217058842,"marketStatus":"Not Yet Opened","change":19.3,"latestTime":"10-22 16:08:15","open":169,"high":217,"low":168.9,"amount":1531610059,"amplitude":0.278518,"askPrice":192.1,"askSize":3000,"bidPrice":192,"bidSize":28500,"shortable":0,"etf":0,"ttmEps":-0.6770116514718224,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1761183000000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":172.7,"openAndCloseTimeList":[[1761096600000,1761105600000],[1761109200000,1761120000000]],"volumeRatio":1.1959621938122804,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784765,"volumeRatio":1.1959621938122804,"shares":397000000,"dividePrice":0,"high":217,"amplitude":0.278518,"preClose":172.7,"low":168.9,"week52Low":20.2,"pbRate":"120.05","week52High":679.5,"institutionHeld":0,"latestPrice":192,"committee":0.809524,"eps":-0.7847647217058842,"divideRate":0,"volume":7860556,"delay":0,"ttmEps":-0.6770116514718224,"open":169,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":113.5,"twentyDayClose":147.7,"sixtyDayClose":38.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-21","current":-283.620572,"percent":0.035714,"low":-380.446233,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"high":-17.403134,"avg":-102.901877,"sd":82.505554,"marketCap":68544221219},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-21","current":-264.885138,"twenty":-184.903189,"median":-58.041658,"eighty":-41.987471,"marketCap":68544221219}],"updateTime":1761152556717},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545778427","title":"TransThera Gets US FDA Fast Track Designation for Prostate Cancer Drug; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545778427","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545778427?lang=en_us&edition=fundamental","pubTime":"2025-06-24 10:01","pubTimestamp":1750730465,"startTime":"0","endTime":"0","summary":"TransThera Sciences  said the US Food and Drug Administration has granted fast-track designation for tinengotinib to treat metastatic castration-resistant prostate cancer , according to a Tuesday Hong Kong bourse filing.In a phase 1/2 study, the drug showed a 46% objective response rate and 85% disease control rate among 13 mCRPC patients with measurable disease, the filing said.TransThera said the latest designation reflects consistent clinical execution and supports further development of the drug for advanced prostate cancer.Shares of the clinical-stage biopharmaceutical firm rose about 3% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00BFXG0V08.USD","BK4585","BK4104","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","BK4567","02617","FAST"],"gpt_icon":1},{"id":"2545271254","title":"BRIEF-Transthera Sciences (Nanjing) Inc Says Grant Of Tinengotinib (Tt-00420) Fast Track Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2545271254","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545271254?lang=en_us&edition=fundamental","pubTime":"2025-06-24 09:59","pubTimestamp":1750730399,"startTime":"0","endTime":"0","summary":"BRIEF-Transthera Sciences  Inc Says Grant Of Tinengotinib  Fast Track DesignationJune 24  - TransThera Sciences  Inc 2617.HK:GRANT OF TINENGOTINIB  FAST TRACK DESIGNATION FOR TREATMENT OF MCRPC BY US FDAFurther company coverage: 2617.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SQ0VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"1112813016","title":"HK Movers | Biopharmaceutical Company TransThera Soars 80% on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1112813016","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112813016?lang=en_us&edition=fundamental","pubTime":"2025-06-23 11:13","pubTimestamp":1750648381,"startTime":"0","endTime":"0","summary":"On debut today, Biopharmaceutical company TransThera soared 80% in Hong Kong.The company has yet to bring any products to market, but it has six drug candidates in clinical trials and one in pre-clini","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b427ba95419e94342a8c5dcdde518cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":1},{"id":"1139156968","title":"Stock Track | TransThera Sciences Soars 63% on Hong Kong Debut Following Oversubscribed IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1139156968","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139156968?lang=en_us&edition=fundamental","pubTime":"2025-06-23 09:34","pubTimestamp":1750642447,"startTime":"0","endTime":"0","summary":"TransThera Sciences  made a spectacular debut on the Hong Kong Stock Exchange, with its shares soaring 63.12% in early trading. The impressive rally comes on the heels of the company's highly successful initial public offering , which raised HK$161.3 million in net proceeds.The clinical-stage biopharmaceutical firm's IPO garnered significant investor interest, particularly in its Hong Kong component. The local offering was an astounding 3,419.87 times oversubscribed, prompting the company to dou","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b427ba95419e94342a8c5dcdde518cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Stock Track | TransThera Sciences Soars 63% on Hong Kong Debut Following Oversubscribed IPO","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02617"],"gpt_icon":1},{"id":"2545459574","title":"TransThera Sciences Raises HK$161 Million from IPO Ahead of Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2545459574","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545459574?lang=en_us&edition=fundamental","pubTime":"2025-06-23 07:28","pubTimestamp":1750634906,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing) (HKG:2617) raised HK$161.3 million in net proceeds from its initial public offering in Hong Kong, according to a Friday after-market filing with the Hong Kong bourse.The ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"df918633255108433bafea673bf4d3c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02617"],"gpt_icon":1},{"id":"2543579573","title":"TransThera Sciences Launches Up to HK$201 Million IPO in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2543579573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543579573?lang=en_us&edition=fundamental","pubTime":"2025-06-13 11:06","pubTimestamp":1749783992,"startTime":"0","endTime":"0","summary":"TransThera Sciences  launched its initial public offering in Hong Kong that seeks to raise up to HK$200.9 million, according to a Friday Hong Kong bourse filing.The clinical-stage biopharmaceutical firm is offering as much as 15,281,000 shares at an indicative price of HK$13.15 each.TransThera secured five cornerstone investors, including Jiangbei Pharmaceutical, Akeso , Sinohsc Honest, Pharmablock Horizon, and Kelingan, which committed to subscribe for a combined HK$130.0 million worth of IPO shares, representing around 64.1% of the offering.The issuer expects to determine its offer price and disclose the allocations on June 20. It will then start trading on the Hong Kong bourse on June 23, according to a prospectus filing.Proceeds from the deal will primarily fund a multiregional Phase III trial of its core product Tinengotinib, with remaining funds allocated to general working capital and corporate purposes.CLSA, Huatai Financial, BOCOM International, BOCI Asia, CMB International, S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02617","BK1574","IE00B543WZ88.USD","LU0348783233.USD","LU1720050803.USD","LU2488822045.USD","LU0417516571.SGD","LU1794554557.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU0348784397.USD","09926"],"gpt_icon":0},{"id":"2543524819","title":"BRIEF-Transthera Sciences (Nanjing) Says Number Of Offer Shares Under Global Offering 15.3 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2543524819","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543524819?lang=en_us&edition=fundamental","pubTime":"2025-06-13 09:24","pubTimestamp":1749777891,"startTime":"0","endTime":"0","summary":"BRIEF-Transthera Sciences  Says Number Of Offer Shares Under Global Offering 15.3 Million H SharesJune 13  - Transthera Sciences  2617.HK:NUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 15.3 MILLION H SHARESOFFER PRICE UNDER GLOBAL OFFERING HK$13.15 PER H SHARENUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 1.5 MILLION H SHARESFurther company coverage: [ ] ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nFWN3SF0MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":47,"code":"91000000","status":"200"}]}}